{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:40:49Z","timestamp":1779882049806,"version":"3.53.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.vaccine.2013.03.016","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T09:38:32Z","timestamp":1363858712000},"page":"4235-4240","source":"Crossref","is-referenced-by-count":41,"title":["Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies"],"prefix":"10.1016","volume":"31","author":[{"given":"Asisa","family":"Volz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.03.016_bib0005","first-page":"S23","article-title":"EMA\/CHMP\/VWP\/141697\/2009 guideline on quality, non-clinical and clinical aspects of live recombinant viral vectored vaccines","volume":"127","author":"Baylor","year":"2011","journal-title":"Pediatrics"},{"issue":"195","key":"10.1016\/j.vaccine.2013.03.016_bib0010","first-page":"24","article-title":"Ver\u00e4nderung von Vaccinevirus durch Dauerpassagen in H\u00fchnerembryofibroblastenkulturen","volume":"I","author":"Mayr","year":"1964","journal-title":"Zentralbl Bakteriol B"},{"issue":"5-6","key":"10.1016\/j.vaccine.2013.03.016_bib0015","first-page":"375","article-title":"The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl Bakteriol B"},{"issue":"47","key":"10.1016\/j.vaccine.2013.03.016_bib0020","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1055\/s-0028-1108143","article-title":"MVA-Stufenimpfung gegen Pocken","volume":"99","author":"Stickl","year":"1974","journal-title":"Dtsch Med Wochenschr"},{"issue":"2","key":"10.1016\/j.vaccine.2013.03.016_bib0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the Modified Vaccinia Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"Antoine","year":"1998","journal-title":"Virology"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2013.03.016_bib0030","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"J Gen Virol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2013.03.016_bib0035","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JVI.74.2.923-933.2000","article-title":"Biology of attenuated Modified Vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the western reserve strain and advantages as a vaccine","volume":"74","author":"Ram\u00edrez","year":"2000","journal-title":"J Virol"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2013.03.016_bib0040","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc Natl Acad Sci"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2013.03.016_bib0045","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1128\/JVI.74.9.4236-4243.2000","article-title":"Protective immunity in macaques vaccinated with a Modified Vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies","volume":"74","author":"Stittelaar","year":"2000","journal-title":"J Virol"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2013.03.016_bib0050","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6383","key":"10.1016\/j.vaccine.2013.03.016_bib0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/358253a0","article-title":"Cytotoxic T-lymphocyte activation involves a cascade of signalling and adhesion events","volume":"358","author":"O\u2019Rourke","year":"1992","journal-title":"Nature"},{"issue":"November (21)","key":"10.1016\/j.vaccine.2013.03.016_bib0060","doi-asserted-by":"crossref","first-page":"11925","DOI":"10.1128\/JVI.00903-07","article-title":"Cross-priming of cytotoxic T cells dictates antigen requisites for Modified Vaccinia virus Ankara vector vaccines","volume":"81","author":"Gasteiger","year":"2007","journal-title":"J Virol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2013.03.016_bib0065","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/CVI.00038-12","article-title":"DNA and Modified Vaccinia virus Ankara vaccines encoding multiple cytotoxic and helper T-lymphocyte epitopes of human immunodeficiency virus type 1 (HIV-1) are safe but weakly immunogenic in HIV-1-uninfected, vaccinia virus-naive adults","volume":"19","author":"Gorse","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2013.03.016_bib0070","doi-asserted-by":"crossref","first-page":"9782","DOI":"10.1128\/JVI.00694-12","article-title":"Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo","volume":"86","author":"Schliehe","year":"2012","journal-title":"J Virol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.03.016_bib0075","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JVI.70.6.3741-3752.1996","article-title":"Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in Modified Vaccinia virus Ankara","volume":"70","author":"Hirsch","year":"1996","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2013.03.016_bib0080","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/0264-410X(94)90341-7","article-title":"A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus","volume":"12","author":"Sutter","year":"1994","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2013.03.016_bib0085","doi-asserted-by":"crossref","first-page":"e1000480","DOI":"10.1371\/journal.ppat.1000480","article-title":"Innate immune sensing of Modified Vaccinia virus Ankara (MVA) is mediated by TLR2\u2013TLR6, MDA-5 and the NALP3 inflammasome","volume":"5","author":"Delaloye","year":"2009","journal-title":"PLoS Pathog"},{"issue":"November (12)","key":"10.1016\/j.vaccine.2013.03.016_bib0090","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.20091472","article-title":"Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells","volume":"206","author":"Halle","year":"2009","journal-title":"J Exp Med"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2013.03.016_bib0095","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1128\/JVI.01884-08","article-title":"Modified Vaccinia virus Ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression","volume":"83","author":"Lehmann","year":"2009","journal-title":"J Virol"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2013.03.016_bib0100","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1128\/JVI.01190-07","article-title":"Modified Vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses","volume":"81","author":"Waibler","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.03.016_bib0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-61779-876-4_4","article-title":"Easy and efficient protocols for working with recombinant vaccinia virus MVA","author":"Kremer","year":"2012","journal-title":"Vaccinia Virus Poxvirol Methods Protoc"},{"issue":"November (21)","key":"10.1016\/j.vaccine.2013.03.016_bib0110","doi-asserted-by":"crossref","first-page":"11468","DOI":"10.1128\/JVI.05165-11","article-title":"The HIV\/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens","volume":"85","author":"G\u00f3mez","year":"2011","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.03.016_bib0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/14760584.8.1.13","article-title":"IMVAMUNE\u00ae: Modified Vaccinia Ankara strain as an attenuated smallpox vaccine","volume":"8","author":"Kennedy","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2013.03.016_bib0120","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1128\/JVI.70.9.6418-6424.1996","article-title":"Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza","volume":"70","author":"Bender","year":"1996","journal-title":"J Virol"},{"issue":"43","key":"10.1016\/j.vaccine.2013.03.016_bib0125","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1016\/j.vaccine.2011.08.014","article-title":"Vaccination strategies to protect children against seasonal and pandemic influenza","volume":"29","author":"Rimmelzwaan","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2013.03.016_bib0130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/erv.09.4","article-title":"Candidate influenza vaccines based on recombinant Modified Vaccinia virus Ankara","volume":"8","author":"Rimmelzwaan","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"10.1016\/j.vaccine.2013.03.016_bib0135","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.vaccine.2005.08.091","article-title":"Immunization with recombinant Modified Vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge","volume":"24","author":"Breathnach","year":"2006","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2013.03.016_bib0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.vetimm.2003.11.004","article-title":"Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination","volume":"98","author":"Breathnach","year":"2004","journal-title":"Vet Immunol Immunopathol"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2013.03.016_bib0145","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1086\/595984","article-title":"Recombinant Modified Vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques","volume":"199","author":"Kreijtz","year":"2009","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2013.03.016_bib0150","doi-asserted-by":"crossref","first-page":"e12217","DOI":"10.1371\/journal.pone.0012217","article-title":"A pandemic influenza H1N1 live vaccine based on Modified Vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations","volume":"5","author":"Hessel","year":"2010","journal-title":"PLoS ONE"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2013.03.016_bib0155","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1099\/vir.0.024885-0","article-title":"Evaluation of a Modified Vaccinia virus Ankara (MVA)-based candidate pandemic influenza A\/H1N1 vaccine in the ferret model","volume":"91","author":"Kreijtz","year":"2010","journal-title":"J Gen Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2013.03.016_bib0160","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri3259","article-title":"The immunological life cycle of tuberculosis","volume":"12","author":"Ernst","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.03.016_bib0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri2902","article-title":"Experimental human challenge infections can accelerate clinical malaria vaccine development","volume":"11","author":"Sauerwein","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"March (142)","key":"10.1016\/j.vaccine.2013.03.016_bib0170","first-page":"w13535","article-title":"HIV vaccines: an attainable goal?","volume":"2","author":"Reynell","year":"2012","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"10.1016\/j.vaccine.2013.03.016_bib0175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4161\/hv.6.1.10116","article-title":"Prime-boost vectored malaria vaccines: progress and prospects","volume":"6","author":"Hill","year":"2010","journal-title":"Human Vaccines"},{"issue":"46","key":"10.1016\/j.vaccine.2013.03.016_bib0180","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1016\/j.vaccine.2011.08.098","article-title":"Safety and immunogenicity of a modified pox vector-based HIV\/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: a phase I clinical trial (RISVAC02)","volume":"29","author":"Garc\u00eda","year":"2011","journal-title":"Vaccine"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2013.03.016_bib0185","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/jiq105","article-title":"Phase 1 safety and immunogenicity testing of DNA and recombinant Modified Vaccinia Ankara vaccines expressing HIV-1 virus-like particles","volume":"203","author":"Goepfert","year":"2011","journal-title":"J Infect Dis"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2013.03.016_bib0190","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/592507","article-title":"Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant Modified Vaccinia virus Ankara","volume":"198","author":"Sandstr\u00f6m","year":"2008","journal-title":"J Infect Dis"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2013.03.016_bib0195","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1128\/JVI.02329-09","article-title":"Preclinical studies of a Modified Vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect","volume":"84","author":"Brandler","year":"2010","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2013.03.016_bib0200","doi-asserted-by":"crossref","first-page":"e35485","DOI":"10.1371\/journal.pone.0035485","article-title":"Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV\/AIDS of clade C","volume":"7","author":"G\u00f3mez","year":"2012","journal-title":"PLoS ONE"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.03.016_bib0205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1089\/aid.2011.0234","article-title":"The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies","volume":"28","author":"Van Rompay","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2013.03.016_bib0210","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1128\/JVI.76.14.7187-7202.2002","volume":"76","author":"Horton","year":"2002","journal-title":"J Virol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2013.03.016_bib0215","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1099\/0022-1317-83-4-807","article-title":"Immunization with recombinant Modified Vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques","volume":"83","author":"Nilsson","year":"2002","journal-title":"J Gen Virol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2013.03.016_bib0220","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.4049\/jimmunol.1000751","article-title":"Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA\/MVA vaccine","volume":"185","author":"Kannanganat","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.03.016_bib0225","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/gt.2008.152","article-title":"Effect of therapeutic immunization using Ad5\/35 and MVA vectors on SIV infection of rhesus monkeys undergoing antiretroviral therapy","volume":"16","author":"Shimada","year":"2008","journal-title":"Gene Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2013.03.016_bib0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/gt.2009.122","article-title":"Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys","volume":"17","author":"Wang","year":"2009","journal-title":"Gene Ther"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2013.03.016_bib0235","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1084\/jem.20082831","article-title":"Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1","volume":"206","author":"Keele","year":"2009","journal-title":"J Exp Med"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2013.03.016_bib0240","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/infdis\/jir199","article-title":"Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA\/Modified Vaccinia Ankara simian immunodeficiency virus vaccine","volume":"204","author":"Lai","year":"2011","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2013.03.016_bib0245","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.vaccine.2011.12.026","article-title":"SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses","volume":"30","author":"Lai","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2013.03.016_bib0250","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox vaccines: targets of protective immunity","volume":"239","author":"Moss","year":"2011","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2013.03.016_bib0255","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virol.2005.06.043","article-title":"The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection","volume":"341","author":"Coulibaly","year":"2005","journal-title":"Virology"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.03.016_bib0260","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1073\/pnas.262668999","article-title":"Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines","volume":"100","author":"Drexler","year":"2003","journal-title":"Proc Natl Acad Sci"},{"issue":"6979","key":"10.1016\/j.vaccine.2013.03.016_bib0265","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2013.03.016_bib0270","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified Vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"Stittelaar","year":"2005","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2013.03.016_bib0275","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2013.03.016_bib0280","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1099\/vir.0.81090-0","article-title":"Ectromelia virus: the causative agent of mousepox","volume":"86","author":"Esteban","year":"2005","journal-title":"J Gen Virol"},{"issue":"October","key":"10.1016\/j.vaccine.2013.03.016_bib0285","first-page":"553","article-title":"Mousepox (infectious ectromelia): past, present, and future","volume":"31","author":"Fenner","year":"1981","journal-title":"Lab Anim Sci"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.03.016_bib0290","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1086\/595565","article-title":"Postexposure immunization with Modified Vaccinia virus Ankara or conventional lister vaccine provides solid protection in a murine model of human smallpox","volume":"199","author":"Paran","year":"2009","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2013.03.016_bib0295","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI33940","article-title":"Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection","volume":"118","author":"Samuelsson","year":"2008","journal-title":"J Clin Invest"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2013.03.016_bib0300","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1099\/vir.0.82068-0","article-title":"Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with Modified Vaccinia virus Ankara","volume":"87","author":"Staib","year":"2006","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2013.03.016_bib0305","doi-asserted-by":"crossref","first-page":"e1002557","DOI":"10.1371\/journal.ppat.1002557","article-title":"Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox","volume":"8","author":"Kremer","year":"2012","journal-title":"PLoS Pathog"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2013.03.016_bib0310","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1099\/vir.0.010553-0","article-title":"Evaluation of smallpox vaccines using variola neutralization","volume":"90","author":"Damon","year":"2009","journal-title":"J Gen Virol"},{"issue":"51","key":"10.1016\/j.vaccine.2013.03.016_bib0315","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1016\/j.vaccine.2007.10.017","article-title":"Clinical and immunologic responses to multiple doses of IMVAMUNE\u00ae (Modified Vaccinia Ankara) followed by Dryvax\u00ae challenge","volume":"25","author":"Frey","year":"2007","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2013.03.016_bib0320","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.vaccine.2007.12.059","article-title":"Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine","volume":"26","author":"Ferrier-Rembert","year":"2008","journal-title":"Vaccine"},{"issue":"August (31)","key":"10.1016\/j.vaccine.2013.03.016_bib0325","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1073\/pnas.0804985105","article-title":"Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus","volume":"105","author":"Earl","year":"2008","journal-title":"Proc Natl Acad Sci"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2013.03.016_bib0330","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/517614","article-title":"Recombinant Modified Vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1","volume":"195","author":"Kreijtz","year":"2007","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2013.03.016_bib0335","doi-asserted-by":"crossref","first-page":"e7790","DOI":"10.1371\/journal.pone.0007790","article-title":"MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A\/H5N1 viruses at low doses and after single immunization","volume":"4","author":"Kreijtz","year":"2009","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2013.03.016_bib0340","doi-asserted-by":"crossref","first-page":"e16247","DOI":"10.1371\/journal.pone.0016247","article-title":"Vectors based on Modified Vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity","volume":"6","author":"Hessel","year":"2011","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13003009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13003009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T04:43:54Z","timestamp":1595565834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13003009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":68,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0264410X13003009"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.03.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}